By Bekah McBride A new approach is paving the way for improved stem cell therapies and regenerative applications using cells from pigs. Led by Wan-Ju Li, a SCRMC researcher and associate professor in the Department …
News
Jacques Galipeau featured in The Medicine Maker
Stem Cell Regenerative Medicine Center (SCRMC) researcher and The International Society for Cell and Gene Therapy President, Jacques Galipeau shares his vision for the future of cell and gene therapies in a new article published …
See-through zebrafish, new imaging method put blood stem cells in high-resolution spotlight
By Bekah McBride For the first time, researchers can get a high-resolution view of single blood stem cells thanks to a little help from microscopy and zebrafish. Researchers at the University of Wisconsin–Madison and the …
New study identifies protein essential to form stem cell-derived human heart cells
By Bekah McBride Lab-grown human heart cells provide a powerful tool to understand and potentially treat heart disease. However, the methods to produce human heart cells from pluripotent stem cells are not optimal. Fortunately, a …
SCRMC researchers uncover how stem cell-derived photoreceptors reach their targets
A new study investigating the growth of photoreceptors may have implications for the treatment of retinal diseases that cause blindness. The study, published in Cell Reports, was led by Stem Cell and Regenerative Medicine (SCRMC) …
Jacques Galipeau named president of the International Society for Cell and Gene Therapy
By Bekah McBride Increasing place of care manufacturing and deployment of cell therapies is a core mission for Jacques Galipeau, MD, who was recently named president of the International Society for Cell and Gene Therapy …
Team of SCRMC researchers awarded Research Forward grant
A team of Stem Cell & Regenerative Medicine Center (SCRMC) researchers will investigate cell therapy as a treatment for brain disorders, injuries, and aging thanks to a Research Forward grant.
Clinical Hematopoietic Cell Processing Laboratory achieves more than minimal manipulation accreditation from FACT
Peiman Hematti, MD, is the director of Clinical Hematopoietic Cell Processing Laboratory at UW-Madison. Much of his research is aimed at improving post-transplant immunological complications, such as graft-versus-host disease. But Hematti and his team are …
When age is more than a number: undergraduate SCRMC lab member Samuel Neuman focuses on regenerative medicine as a way to impede diseases of degeneration and aging
By Bekah McBride Aging is part of the human experience, but not every experience is the same. Progressive neurodegenerative diseases such as Parkinson’s, Huntington’s, and Alzheimer’s disease present many challenges to patients and their families, …
SCRMC Director Tim Kamp pens perspectives piece for Quarterly magazine
Nearly twenty-five years ago, University of Wisconsin-Madison researcher James Thomson described the first successful derivation of human embryonic stem cells (hESCs). These cells, which are pluripotent, meaning they can form any cell type and self-renewing, meaning they can grow indefinitely in culture, changed the way diseases are understood and treated. While the past two decades have included dramatic advances, there is still much to learn, and clinical trials are just beginning for a variety of degenerative diseases. Dr. Kamp outlines the opportunities, challenges, and the history of stem cell research in his column “Stem Cells and Regenerative Medicine: A long, but promising road” available on page 40 of the spring 2022 Quarterly magazine.